<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">surgonco</journal-id><journal-title-group><journal-title xml:lang="ru">Креативная хирургия и онкология</journal-title><trans-title-group xml:lang="en"><trans-title>Creative surgery and oncology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2076-3093</issn><issn pub-type="epub">2307-0501</issn><publisher><publisher-name>Башкирский государственный медицинский университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24060/2076-3093-2018-8-3-190-195</article-id><article-id custom-type="elpub" pub-id-type="custom">surgonco-330</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Особенности лимфы и ее реологии при раке как фактор метастазирования (на примере рака молочной железы)</article-title><trans-title-group xml:lang="en"><trans-title>Peculiarities of Lymph Fluid and Its Rheology as a Metastasisin</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Султанбаев</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sultanbaev</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., зав. отделением амбулаторной химиотерапии, Россия, 450054, Уфа, пр-т Октября, 73/1.</p></bio><bio xml:lang="en"><p>Candidate of Medical Sciences, Head of the Department of Outpatient Chemotherapy, 73/1 Oktyabrya avenue, Ufa, 450054, Russian Federation.</p></bio><email xlink:type="simple">sovaa@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7562-5684</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ганцев</surname><given-names>К. Ш.</given-names></name><name name-style="western" xml:lang="en"><surname>Gantsev</surname><given-names>K. Sh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор кафедры онкологии с курсами онкологии и патологической анатомии ИДПО, Россия, 450008, Уфа, ул. Ленина, 3.</p></bio><bio xml:lang="en"><p>Doctor of Medical Sciences, Professor of the Department of Oncology with Oncology and Anatomical Pathology courses in the Institute of Additional Professional Education, 3 Lenin str., Ufa, 450008, Russian Federation.</p></bio><email xlink:type="simple">gantseff@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9721-108X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кзыргалин</surname><given-names>Ш. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Kzyrgalin</surname><given-names>Sh. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., доцент кафедры онкологии с курсами онкологии и патологической анатомии ИДПО, Россия, 450008, Уфа, ул. Ленина, 3.</p></bio><bio xml:lang="en"><p>Candidate of Medical Sciences, Associate Professor of the Department of Oncology with Oncology and Anatomical Pathology courses in the Institute of Additional Professional Education, 3 Lenin str., Ufa, 450008, Russian Federation.</p></bio><email xlink:type="simple">ufa.shamil@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3721-4040</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Азизов</surname><given-names>Н. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Mansurovich</surname><given-names>N. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>клинический ординатор кафедры онкологии с курсами онкологии и патологической анатомии ИДПО, Россия, 450008, Уфа, ул. Ленина, 3.</p></bio><bio xml:lang="en"><p>Medical Resident of the Department of Oncology with Oncology and Anatomical Pathology courses in the Institute of Additional Professional Education, 3 Lenin str., Ufa, 450008, Russian Federation.</p></bio><email xlink:type="simple">nailazizov197@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Республиканский клинический онкологический диспансер.</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Republican Clinical Oncology Centre.</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Башкирский государственный медицинский университет.</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Bashkir State Medical University.</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>25</day><month>01</month><year>2019</year></pub-date><volume>8</volume><issue>3</issue><fpage>190</fpage><lpage>195</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Султанбаев А.В., Ганцев К.Ш., Кзыргалин Ш.Р., Азизов Н.М., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Султанбаев А.В., Ганцев К.Ш., Кзыргалин Ш.Р., Азизов Н.М.</copyright-holder><copyright-holder xml:lang="en">Sultanbaev A.V., Gantsev K.S., Kzyrgalin S.R., Mansurovich N.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.surgonco.ru/jour/article/view/330">https://www.surgonco.ru/jour/article/view/330</self-uri><abstract><p>Введение. Несмотря на многочисленность научных исследований по проблемам метастазирования, вопросы состояния жидких сред (лимфы и крови) при онкологических заболеваниях оставались без достаточного внимания.Материалы и методы. Изучались свойства лимфы у женщин со злокачественными новообразованиями молочной железы. Вязкость лимфы определена у 100 больных раком молочной железы. Возраст пациентов имел диапазон от 50 до 80 лет. Все пациентки были в менопаузе. Материал для определения вязкости забирался на 5–7 сутки после мастэктомии с расширенной лимфодиссекцией аксиллярных лимфоузлов. На первые-вторые сутки содержимое раны было представлено кровяными сгустками и серозной жидкостью. На 3–5 сутки отделяемое раны состояло из серозного отделяемого, прелимфы и лимфы. На пятые сутки и последующие дни в отделяемом из раны превалировала лимфа, что обусловлено завершившимся гемостазом и сохранением отделяемого из мелких лимфатических сосудов.Результаты. Метастатический процесс проходит более активно при начальных стадиях рака, так как среда метастазирования представлена лимфой менее вязкой, а сосуды в своем большинстве сохраняют проходимость. При продвинутых стадиях рака, когда повышается вязкость лимфы, процессы метастазирования замедляются. Выводы. 1. При раке молочной железы вязкость зависит от стадии рака, при этом лимфа в бассейне опухоли ведет себя как неньютоновская жидкость. 2. При I–II стадии рака метастазирование происходит более активно, чем при раке с продвинутыми стадиями. Этот феномен определяется реологическими свойствами лимфы и степенью функциональной состоятельности регионарной сосудистой системы.</p></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Despite the large number of scientific studies on metastasis problems, the state of liquid media (lymph and blood) in oncological diseases remained without sufficient attention.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. A study of the lymph fluid properties, including viscosity, of 100 female patients with malignant breast tumours was carried out. The age of the patients ranged from 50 to 80 years. All patients were in menopause. The material for determination of viscosity was taken 5–7 days following mastectomy with extended dissection of axillary lymph nodes. On the first and second days, the contents of the wound were represented by blood clots and serous fluid. Between three- and five-days following surgery, the discharge from the wound consisted of serous discharge, prelims and lymph. On the fifth day and the following days, the wound discharge consisted primarily of lymph fluid caused by the completed haemostasis and continuation of discharge from the small lymphatic vessels.</p></sec><sec><title>Results</title><p>Results. The metastatic process is more active during the initial stages of cancer, since the metastatic medium is represented by less viscous lymph fluid while the vessels for the most part retain their permeability. With advanced stages of cancer, when the viscosity of the lymph rises, metastasis slows down.</p></sec><sec><title>Conclusions</title><p>Conclusions: (1) In breast cancer, the viscosity depends on the stage of the cancer, while the lymph in the tumour pool behaves like a non-Newtonian fluid. (2) In stages I-II of cancer, metastasis occurs more actively than in cancer at more advanced stages. This phenomenon is determined by the rheological properties of the lymph and the functional viability of the regional vascular system.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>молочной железы новообразования</kwd><kwd>мастэктомия</kwd><kwd>метастазы</kwd><kwd>лимфа</kwd><kwd>вязкость</kwd><kwd>реология</kwd></kwd-group><kwd-group xml:lang="en"><kwd>breast neoplasms</kwd><kwd>mastectomy</kwd><kwd>neoplasm metastasis</kwd><kwd>lymph</kwd><kwd>viscosity</kwd><kwd>rheology</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ohhashi T., Kawai Y. Proposed new lymphology combined with lymphatic physiology, innate immunology, and oncology. JPS. 2015;65(1):51–66. DOI: 10.1007/s12576-014-0343-6</mixed-citation><mixed-citation xml:lang="en">Ohhashi T., Kawai Y. Proposed new lymphology combined with lymphatic physiology, innate immunology, and oncology. JPS. 2015;65(1):51–66. DOI: 10.1007/s12576-014-0343-6</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Lv L., Ma R.M., Yang F., Zhang X.H., Huang D.P. Lymphangiogenesis in breast cancer is associated with non-sentinel lymph node metastases in sentinel node positive patients. Int J Clin Experim Pathol. 2015;8(9):11171–7. PMCID: PMC4637653</mixed-citation><mixed-citation xml:lang="en">Lv L., Ma R.M., Yang F., Zhang X.H., Huang D.P. Lymphangiogenesis in breast cancer is associated with non-sentinel lymph node metastases in sentinel node positive patients. Int J Clin Experim Pathol. 2015;8(9):11171–7. PMCID: PMC4637653</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Триголосов А.В., Уйманов В.А., Черных М.В., Петровский А.В., Никитина Е.А., Нечушкин М.И. Метастазы рака молочной железы в парастернальные лимфоузлы: нужна ли морфологическая верификация? Современная онкология. 2017;19(2):22–7.</mixed-citation><mixed-citation xml:lang="en">Trigolosov A.V., Uimanov V.A., Chernikh M.V., Petrovskiy A.V., Nikitina E.A., Nechushkin M.I. Internal mammary nodes metastases for breast cancer: whether the morphological verification is necessary? Journal of Modern Oncology. 2017;19(2):22–7. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ермаганбетова А.Т., Макишев А.К., Иманбаев Х.А. Роль сигнальных лимфатических узлов при раке молочной железы. Современное состояние проблемы. Клиническая медицина Казахстана. 2017;(2):15–8.</mixed-citation><mixed-citation xml:lang="en">Yermagambetova A., Makishev A., Imanbayev Kh. The role of sentinel lymph nodes in breast cancer. The current state of the problem. Journal of Clinical Medicine of Kazakhstan. 2017;(2):15–8. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Манихас Г.М., Лойт А.А., Звонарёв Е.Г., Гуслев А.Б. Особенности лимфогенного метастазирования рака молочной железы. Вопросы реконструктивной и пластической хирургии. 2016;19(1):26–32.</mixed-citation><mixed-citation xml:lang="en">Manikhas G.M., Loyt A.A., Zvonarev Ye.G., Guslev A.B. Features of nodal metastasis in breast cancer. Issues of Reconstructive and Plastic Surgery. 2016;19(1):26–32. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Wiig H., Swartz M.A. Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer. Physiol Rev. 2012;92(3):1005–60. DOI: 10.1152/physrev.00037.2011</mixed-citation><mixed-citation xml:lang="en">Wiig H., Swartz M.A. Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer. Physiol Rev. 2012;92(3):1005–60. DOI: 10.1152/physrev.00037.2011</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Guleria P., Srinivas V., Basannar D., Dutta V. Comparison of lymphangiogenesis, lymphatic invasion, and axillary lymph node metastasis in breast carcinoma. Indian J Pathol Microbiol. 2018;61(2):176–80. DOI: 10.4103/IJPM.IJPM_774_16</mixed-citation><mixed-citation xml:lang="en">Guleria P., Srinivas V., Basannar D., Dutta V. Comparison of lymphangiogenesis, lymphatic invasion, and axillary lymph node metastasis in breast carcinoma. Indian J Pathol Microbiol. 2018;61(2):176–80. DOI: 10.4103/IJPM.IJPM_774_16</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Султанбаев А.В., Фролова В.Ю. Белковый баланс периферической лимфы — показатель противоопухолевой резистентности организма. Вестник Башкирского государственного медицинского университета. 2013;(1):60–5.</mixed-citation><mixed-citation xml:lang="en">Sultanbaev A.V., Frolova V.Yu. Protein balance in peripheral lymph — indicator of the antineoplastic resistance of the organism. Vestnik Bashkirskogo gosudarstvennogo medizhinskogo universiteta. 2013;(1):60–5. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ганцев Ш.Х., Урманчеев С.Ф., Султанбаев А.В., Киреев В.Н., Ишмуратова Р.Ш., Абрамова О.А. Математическое моделирование лимфоциркуляции при раке молочной железы. Евразийский онкологический журнал. 2014;(1):24–33.</mixed-citation><mixed-citation xml:lang="en">Gantsev Sh.Kh., Urmancheyev S.F., Sultanbaev A.V., Kireyev V.N., Ishmuratova R.Sh., Abramova O.A. Mathematical modeling of the lymphatic circulation in breast cancer. Eurasian Journal of Oncology. 2014;(1):24–33. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ozerdem U., Wojcik E.M., Barkan G.A., Duan X., Ersahin C. A practical application of quantitative vascular image analysis in breast pathology. Pathol Res Pract. 2013;209(7):455–8. DOI: 10.1016/j.prp.2013.03.004</mixed-citation><mixed-citation xml:lang="en">Ozerdem U., Wojcik E.M., Barkan G.A., Duan X., Ersahin C. A practical application of quantitative vascular image analysis in breast pathology. Pathol Res Pract. 2013;209(7):455–8. DOI: 10.1016/j.prp.2013.03.004</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Y., Yan J., Yuan Z., Yu S., Yang C., Wang Z. et al. A metaanalysis of the relationship between lymphatic microvessel density and clinicopathological parameters in breast cancer. Bull Cancer. 2013;100(3):1–10.</mixed-citation><mixed-citation xml:lang="en">Chen Y., Yan J., Yuan Z., Yu S., Yang C., Wang Z. et al. A metaanalysis of the relationship between lymphatic microvessel density and clinicopathological parameters in breast cancer. Bull Cancer. 2013;100(3):1–10.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Morley S.T., Newport D.T., Walsh M.T. Towards the prediction of flow-induced shear stress distributions experienced by breast cancer cells in the lymphatics. Biomechanics &amp; Modeling in Mechanobiology. 2017;16(6):2051–62.</mixed-citation><mixed-citation xml:lang="en">Morley S.T., Newport D.T., Walsh M.T. Towards the prediction of flow-induced shear stress distributions experienced by breast cancer cells in the lymphatics. Biomechanics &amp; Modeling in Mechanobiology. 2017;16(6):2051–62.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Завьялова М.В., Телегина Н.С., Вторушин С.В., Перельмутер В.М., Слонимская Е.М., Денисов Е.В. и др. Особенности лимфогенного метастазирования при люминальном а типе рака молочной железы. Сибирский онкологический журнал. 2013;(2):41–4.</mixed-citation><mixed-citation xml:lang="en">Zavjalova M.V., Telegina N.S., Vtorushin S.V., Perelmuter V.M., Slonimskaya E.M., Denisov E.V. et al. Lymphogenic metastasis in luminal-type a breasr cancer. Siberian Journal of Oncology. 2013;(2):41–4. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Keser S.H., Kandemir N.O., Ece D., Gecmen G.G., Gul A.E., Barisik N.O. et al. Relationship of mast cell density with lymphangiogenesis and prognostic parameters in breast carcinoma. Kaohsiung J Med Sci. 2017;33(4):171–80. DOI: 10.1016/j.kjms.2017.01.005</mixed-citation><mixed-citation xml:lang="en">Keser S.H., Kandemir N.O., Ece D., Gecmen G.G., Gul A.E., Barisik N.O. et al. Relationship of mast cell density with lymphangiogenesis and prognostic parameters in breast carcinoma. Kaohsiung J Med Sci. 2017;33(4):171–80. DOI: 10.1016/j.kjms.2017.01.005</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Z.Q., Han Y.Z., Nian Q., Chen G., Cui S.Q., Wang X.Y. Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (&lt;=35 Years). PLoS ONE. 2015;10(12):e0144376.</mixed-citation><mixed-citation xml:lang="en">Zhang Z.Q., Han Y.Z., Nian Q., Chen G., Cui S.Q., Wang X.Y. Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (&lt;=35 Years). PLoS ONE. 2015;10(12):e0144376.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
